🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to evaluate if ME-401 can improve the treatment of...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Start Date
2021-04-28
Trial ID
NCT04517435
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
National Hospital Organization Nagoya Medical Center
Start Date
2019-04-29
Trial ID
NCT03985189
Treatments Being Tested
This is a Phase 3 study of the PI3Kδ inhibitor Zandelisib (ME-401) in combi...
Status
Terminated
Location
The Oncology Institute of Hope and Innovation
Start Date
2021-08-13
Trial ID
NCT04745832
Treatments Being Tested
This research study is being done to estimate the safety and efficacy of za...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05604417
Treatments Being Tested
This is the study of the PI3Kδ inhibitor Zandelisib (ME-401) in subjects wi...
Status
Terminated
Location
Oncology Institute of Hope and Innovation
Start Date
2019-06-25
Trial ID
NCT03768505
Treatments Being Tested
A Phase 2 study of Zandelisib with Venetoclax (VEN) and Rituximab (R) in su...
Status
Withdrawn
Location
Dana Farber Cancer Institute
Start Date
2022-11-22
Trial ID
NCT05209308
Treatments Being Tested
A Three-Arm Study of ME-401 in Subjects with Relapsed/Refractory CLL/SLL or...
Status
Terminated
Location
University of Arizona
Start Date
2016-10
Trial ID
NCT02914938
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Status
Active Not Recruiting
Location
Anjo Kosei Hospital
Start Date
2020-09-17
Trial ID
NCT04533581
Treatments Being Tested